View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

VALLOUREC SHOWCASES THE LATEST INNOVATIONS OF ITS VAM® CONNECTION AT A...

VALLOUREC SHOWCASES THE LATEST INNOVATIONS OF ITS VAM® CONNECTION AT ADIPEC 2025 VALLOUREC SHOWCASES THE LATEST INNOVATIONS OF ITS VAM® CONNECTION AT ADIPEC 2025 Meudon (France), October 21 2025 – Vallourec, a world leader in premium tubular solutions, will participate in ADIPEC 2025, the world’s largest energy industry event, taking place from 3 to 6 November 2025 in Abu Dhabi, United Arab Emirates. This year, Vallourec will highlight the latest innovations of its flagship VAM®connection, as well as its most recent technologies supporting the energy transition. A benchmark in the Oil & G...

 PRESS RELEASE

VALLOUREC PRÉSENTE LES DERNIÈRES INNOVATIONS DE SA CONNEXION VAM® À AD...

VALLOUREC PRÉSENTE LES DERNIÈRES INNOVATIONS DE SA CONNEXION VAM® À ADIPEC 2025                                                                     VALLOUREC PRÉSENTE LES DERNIÈRES INNOVATIONS DE SA CONNEXION VAM® À ADIPEC 2025 Meudon (France), le 21 octobre 2025 – Vallourec, leader mondial des solutions tubulaires premium sans soudure, participera à ADIPEC 2025, le plus grand événement mondial de l’industrie de l’énergie, qui se tiendra du 3 au 6 novembre 2025 à Abou Dabi. Cette année, Vallourec mettra en avant les dernières innovations de sa connexion de référence VAM®, ainsi que ses te...

 PRESS RELEASE

Zealand Pharma major shareholder announcement: Van Herk Investments B....

Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Company announcement – No. 22 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, October 17, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today reports receipt on 16 October 2025 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholder: As of 15 October 2025, Van Herk Investments B.V. ...

 PRESS RELEASE

VALLOUREC : Monthly information relating to the total number of voting...

VALLOUREC : Monthly information relating to the total number of voting rights and shares comprising the share capital VALLOURECFrench limited liability company (société anonyme) with a Board of Directors with share capital of € 4,768,147.86Registered office: 12, rue de la Verrerie – 92190 Meudon, FranceRegistered on the Nanterre Trade and Companies Register under n° 552 142 200 Meudon, October 16th, 2025 Monthly information relating to the total number of voting rightsand shares comprising the share capital Article L. 233-8-II of the French Code de commerce and Article 223-1...

 PRESS RELEASE

VALLOUREC : Information mensuelle relative au nombre total de droits d...

VALLOUREC : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social VALLOURECSociété anonyme à Conseil d’Administrationau capital de 4 768 147,86 € Siège social : 12, rue de la Verrerie – 92190 Meudon552 142 200 RCS Nanterre Meudon, le 16 octobre 2025, Information mensuelle relative au nombre total de droits de voteet d’actions composant le capital social Article L. 233-8-II du Code de commerce et article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Date Nombre totald'actions en circulation Nombre totalde droits de ...

 PRESS RELEASE

Crelan et le Crédit Agricole finalisent leur partenariat stratégique

Crelan et le Crédit Agricole finalisent leur partenariat stratégique Bruxelles, Lille, Montrouge, le 7 octobre 2025 Crelan et le Crédit Agricole finalisent leur partenariat stratégique À la suite de la communication du 21 mai 2025, les groupes Crelan et Crédit Agricole annoncent aujourd’hui avoir finalisé leur partenariat stratégique par la signature d’accords commerciaux et l’acquisition d’une participation minoritaire de 9,9.% dans Crelan SA/NV par le groupe Crédit Agricole. Crelan et le groupe Crédit Agricole vont désormais se concentrer sur la mise en œuvre de collaborations commerci...

 PRESS RELEASE

VALLOUREC SECURES A NEW ORDER WITH PETROBRAS FOR SUBMAGNÉTICO FREE FLO...

VALLOUREC SECURES A NEW ORDER WITH PETROBRAS FOR SUBMAGNÉTICO FREE FLOW® VALLOUREC SECURES A NEW ORDER WITH PETROBRAS FOR SUBMAGNÉTICO FREE FLOW® Meudon (France), October 1st 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces a new order for SUBMAGNÉTICO FREE FLOW®, its Oil Country Tubular Goods (OCTG) solution designed to prevent inorganic scaling in production strings. This new order signed with the Brazilian operator, Petrobras, covers the production and installation of more than 30 units, to be delivered and installed in Brazil’s offshore pre-salt fields....

 PRESS RELEASE

VALLOUREC REMPORTE UNE NOUVELLE COMMANDE AUPRÈS DE PETROBRAS POUR SUBM...

VALLOUREC REMPORTE UNE NOUVELLE COMMANDE AUPRÈS DE PETROBRAS POUR SUBMAGNÉTICO FREE FLOW® VALLOUREC REMPORTE UNE NOUVELLE COMMANDE AUPRÈS DE PETROBRAS POUR SUBMAGNÉTICO FREE FLOW® Meudon (France), le 1er octobre 2025 – Vallourec, leader mondial des solutions tubulaires premium sans soudure, annonce une nouvelle commande pour SUBMAGNÉTICO FREE FLOW®, sa solution OCTG (Oil Country Tubular Goods) conçue pour éviter l'entartrage inorganique dans les colonnes de production. Cette nouvelle commande signée avec l'opérateur brésilien Petrobras porte sur la production et l'installation de plus de 3...

 PRESS RELEASE

Total number of shares and voting rights in Zealand Pharma as of Septe...

Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Company announcement – No. 21 / 2025 Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Copenhagen, Denmark, September 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end o...

 PRESS RELEASE

CREDIT AGRICOLE NORD DE FRANCE : Avis de mise à disposition du rapport...

CREDIT AGRICOLE NORD DE FRANCE : Avis de mise à disposition du rapport financier semestriel Lille, le 29 septembre 2025 COMMUNIQUE AVIS DE MISE A DISPOSITION  DU RAPPORT FINANCIER SEMESTRIEL DU CREDIT AGRICOLE NORD DE FRANCE La Caisse régionale du Credit Agricole Nord de France annonce avoir mis à disposition du public et déposé auprès de l’Autorité des Marchés Financiers son rapport financier semestriel au 30 juin 2025. Le rapport financier semestriel peut être consulté sur le site internet du Crédit Agricole Nord de France à l’adresse , rubrique publications. Contact presse Crédit...

 PRESS RELEASE

Zealand Pharma appoints Rachel James-Owens as Vice President, Corporat...

Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Press release – No. 14 / 2025 Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations Copenhagen, Denmark, September 24, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced the appointment of Rachel James-Owens as Vice President, Corporate Communications & Media Relations. Rachel brings over 20 years of global...

Jacob Mekhael ... (+2)
  • Jacob Mekhael
  • Mathijs Geerts Danau

Life Sciences Conference 25 Sep 2025

KBC Securities will host its annual life sciences conference on 25 September in Brussels. The event will include 14 exciting companies, both public and private, from the BeNeLux ecosystem and beyond. In this conference note, we provide an overview of the attending companies, as well as an outlook on KBC Securities' life sciences broader coverage.

 PRESS RELEASE

JEROME FAVRE APPOINTED HEAD OF OCTG, SERVICES AND ACCESSORIES

JEROME FAVRE APPOINTED HEAD OF OCTG, SERVICES AND ACCESSORIES JEROME FAVRE APPOINTED HEAD OF OCTG, SERVICES AND ACCESSORIES Meudon (France), September 15, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the appointment of Jérôme Favre as Head of the OCTG, Services and Accessories Business Line. He has joined the Executive Committee, effective immediately. Jérôme Favre previously oversaw OCTG sales for the Eastern Hemisphere and is succeeding Laurent Dubedout. He will work closely with Laurent to perpetuate the Group’s successful commercial strategy during...

 PRESS RELEASE

JEROME FAVRE NOMMÉ DIRECTEUR OCTG, SERVICES ET ACCESSOIRES

JEROME FAVRE NOMMÉ DIRECTEUR OCTG, SERVICES ET ACCESSOIRES JEROME FAVRE NOMMÉ DIRECTEUR OCTG,SERVICES ET ACCESSOIRES Meudon (France), 15 septembre 2025 – Vallourec, leader mondial des solutions tubulaires premium sans soudure, annonce la nomination de Jérôme Favre au poste de Directeur Business line OCTG, Services et Accessoires. Il rejoint le Comité Exécutif et prend ses fonctions ce jour. Jérôme Favre pilotait auparavant les ventes OCTG Hémisphère Est, il succède à Laurent Dubedout. Jérôme et Laurent coopéreront étroitement dans les prochaines semaines pour maintenir la dynamique de la ...

Felix Fischer ... (+6)
  • Felix Fischer
  • Haidje Rustau
  • Jayanth Kandalam
  • Peter Low
  • Si Yong Ng
  • Tanvi Arora

Lucror Analytics - Morning Views Europe

In today's Morning Views publication we comment on developments of the following high yield issuers: Playtech, Guala Closures, evoke, Grupo Antolin, Nokia, NES Fircroft, MasOrange, Paprec Group, Biofarma, Vallourec, Forvia (formerly Faurecia), Ineos, Ineos Quattro

 PRESS RELEASE

Zealand Pharma increases its share capital as a result of the exercise...

Zealand Pharma increases its share capital as a result of the exercise of employee warrants Company announcement – No. 20 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 11, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has by decision of the Board of Directors increased its share capital by a nominal amount of DKK 20,924 divided into 20,924 new shares ...

 PRESS RELEASE

PETROBRAS CHOOSES VALLOUREC TO SUPPORT $1BN OFFSHORE OCTG PROJECTS

PETROBRAS CHOOSES VALLOUREC TO SUPPORT $1BN OFFSHORE OCTG PROJECTS PETROBRAS CHOOSES VALLOUREC TO SUPPORT $1BN OFFSHORE OCTG PROJECTS Meudon (France), on September 11, 2025 – Vallourec, a world leader in premium seamless tubular solutions, has been awarded a major contract by Petrobras as a result of a competitive bidding process for the supply of OCTG (Oil Country Tubular Goods) products and services for its offshore operations from 2026 to 2029. This long-term agreement could generate total revenue of up to USD 1 billion, representing the widest award both in volumes and revenues since...

 PRESS RELEASE

PETROBRAS ATTRIBUE À VALLOUREC UN CONTRAT D’UN MILLIARD DE DOLLARS POU...

PETROBRAS ATTRIBUE À VALLOUREC UN CONTRAT D’UN MILLIARD DE DOLLARS POUR SES PROJETS OFFSHORE OCTG Meudon (France), le 11 septembre 2025 – Vallourec, leader mondial des solutions tubulaires premium sans soudure, a remporté un contrat majeur auprès de Petrobras, à la suite d’un appel d’offres compétitif pour la fourniture de produits et services OCTG (Oil Country Tubular Goods) destinés à ses opérations offshore de 2026 à 2029. Cet accord de long terme pourrait générer un chiffre d’affaires total allant jusqu’à 1 milliard de dollars (USD), représentant l’attribution la plus importante en ...

 PRESS RELEASE

SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on...

SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025 Press release – No.13 / 2025 SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025 Copenhagen, Denmark, September 11, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that it will host a Capital Markets Day in London on December 11, 2025, featuring presentations from management and external experts in obesity. “Obesity is one of ...

 PRESS RELEASE

Monthly information relating to the total number of voting rights and ...

Monthly information relating to the total number of voting rights and shares comprising the share capital VALLOURECFrench limited liability company (société anonyme) with a Board of Directors with share capital of € 4,768,147.86Registered office: 12, rue de la Verrerie – 92190 Meudon, FranceRegistered on the Nanterre Trade and Companies Register under n° 552 142 200 Meudon, September 4th, 2025 Monthly information relating to the total number of voting rightsand shares comprising the share capital Article L. 233-8-II of the French Code de commerce and Article 223-16 of the General Regulat...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch